RLMD   $2.8  1.82% Market Closed

Relmada Therapeutics Inc
Total Cash 70.44M
totalCashPerShare 2.334
EBITDA
Total Debt 0.00
quickRatio 7.386
currentRatio 7.442
Total Revenue
debtToEquity
Revenue/Share
ROA -0.5913
ROE -1.00405
grossProfits
freeCashflow -18.51M
operatingCashflow -48.18M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 29.74M
forwardPE -1.5384616
floatShares 27.54M
sharesOutstanding 30.17M
sharesShort 1.26M
sharesShortPriorMonth 1.18M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.46%
Short Ratio help_outline 4.52%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 2.038
Price To Book help_outline 1.67
earningsQuarterlyGrowth
netIncomeToCommon -86.76M
trailingEps -2.87%
forwardEps -2.21%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.64 3Q 2024
institutionsCount 92
lastUpdated Nov. 7, 2024, 3:18 a.m.